drugset / Trial / NCT00041509
ThromboEmbolism Prevention Efficacy and Safety Trial (TEMPEST)
RandomizedParallel-groupQuadruple-blindPrevention
Summary
The purpose of this study is to gain additional safety information as well as to determine after the study drug has been given to patients who have undergone total hip replacement surgery, whether the study drug is effective in preventing late deep vein thrombosis (blood clots in legs) or pulmonary embolism (blood clots in lungs).
Timeline
- Start
- 2002-01
- Primary completion
- 2003-05
- Completion
- 2003-05
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | SB424323 | Unknown | 125 mg | Oral |
| Subject | SB424323 | Unknown | 500 mg | Oral |
Indications
No indication recorded.